Skip to main content
Erschienen in: Der Gynäkologe 4/2014

01.04.2014 | Leitthema

Ovarielle Stimulation bei der prä- und perimenopausalen Patientin

verfasst von: Prof. Dr. T. Strowitzki, M. von Wolff

Erschienen in: Die Gynäkologie | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Zusammenfassung

Kinderwunschtherapien bei Frauen ab 40 Jahren haben eine begrenzte Erfolgschance. Die ovarielle Reserve und die Eizellqualität sind vermindert, die Chancen der „assisted reproduction technology“ (ART) kontinuierlich abnehmend. Die Stimulationsprotokolle zur ovariellen Stimulation unterscheiden sich nicht von denen bei jüngeren Patientinnen. Vorteile der verschiedenen Stimulationsprotokolle speziell für diese Altersgruppe konnten nicht gezeigt werden.
Literatur
1.
Zurück zum Zitat Almog B, Shehata F, Shalom-Paz E et al (2011) Age-related nomogram for antral follicle count: McGill reference guide. Fertil Steril 95:663–666 PubMedCrossRef Almog B, Shehata F, Shalom-Paz E et al (2011) Age-related nomogram for antral follicle count: McGill reference guide. Fertil Steril 95:663–666 PubMedCrossRef
2.
Zurück zum Zitat Almog B, Shehata F, Suissa S et al (2011) Age-related nomograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 95:2359–2363 PubMedCrossRef Almog B, Shehata F, Suissa S et al (2011) Age-related nomograms of serum antimüllerian hormone levels in a population of infertile women: a multicenter study. Fertil Steril 95:2359–2363 PubMedCrossRef
3.
Zurück zum Zitat Baart EB, Martini E, Eijkemans MJ et al (2007) Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 22:980–988 PubMedCrossRef Baart EB, Martini E, Eijkemans MJ et al (2007) Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 22:980–988 PubMedCrossRef
4.
Zurück zum Zitat Berkkanoglu M, Ozgur K (2010) What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil Steril 94:662–665 PubMedCrossRef Berkkanoglu M, Ozgur K (2010) What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil Steril 94:662–665 PubMedCrossRef
5.
Zurück zum Zitat Broekmans FJ, Soules MR, Fauser BC (2009) Ovarian aging: mechanisms and clinical consequences. Endocr Rev 30:465–493 PubMedCrossRef Broekmans FJ, Soules MR, Fauser BC (2009) Ovarian aging: mechanisms and clinical consequences. Endocr Rev 30:465–493 PubMedCrossRef
6.
Zurück zum Zitat Broer SL, Disseldorp J van, Broeze KA et al (2013) Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update 19:26–36 PubMedCrossRef Broer SL, Disseldorp J van, Broeze KA et al (2013) Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update 19:26–36 PubMedCrossRef
7.
Zurück zum Zitat Check JH, Choe JK, Cohen R, Wilson C (2013) A study to determine the efficacy of controlled ovarian hyperstimulation regimen using a gonadotropin releasing hormone agonist versus antagonist in women of advanced reproductive age with varying degrees of oocyte reserve on outcome following in vitro fertilization-embryo transfer. Clin Exp Obstet Gynecol 40:191–192 PubMed Check JH, Choe JK, Cohen R, Wilson C (2013) A study to determine the efficacy of controlled ovarian hyperstimulation regimen using a gonadotropin releasing hormone agonist versus antagonist in women of advanced reproductive age with varying degrees of oocyte reserve on outcome following in vitro fertilization-embryo transfer. Clin Exp Obstet Gynecol 40:191–192 PubMed
8.
Zurück zum Zitat DIR: http://​www.​deutsches-ivf-register.​de DIR: http://​www.​deutsches-ivf-register.​de
9.
Zurück zum Zitat Dunson DB, Colombo B, Baird DD (2002) Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 17:1399–1403 PubMedCrossRef Dunson DB, Colombo B, Baird DD (2002) Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 17:1399–1403 PubMedCrossRef
10.
Zurück zum Zitat Fauser BC, Diedrich K, Devroey P (2008) Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 14:1–14 PubMedCrossRef Fauser BC, Diedrich K, Devroey P (2008) Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update 14:1–14 PubMedCrossRef
11.
Zurück zum Zitat Ferraretti AP, La Marca A, Fauser BC et al (2011) ESHRE consensus on the definition of ‚poor response‘ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26:1616–1624 PubMedCrossRef Ferraretti AP, La Marca A, Fauser BC et al (2011) ESHRE consensus on the definition of ‚poor response‘ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 26:1616–1624 PubMedCrossRef
12.
13.
Zurück zum Zitat Gougeon A (1998) Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas 30:137–142 PubMedCrossRef Gougeon A (1998) Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas 30:137–142 PubMedCrossRef
14.
Zurück zum Zitat Hill MJ, Levy G, Levens ED (2012) Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature. Reprod Biomed Online 24:261–271 PubMedCrossRef Hill MJ, Levy G, Levens ED (2012) Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature. Reprod Biomed Online 24:261–271 PubMedCrossRef
15.
Zurück zum Zitat Hourvitz A, Machtinger R, Maman E et al (2009) Assisted reproduction in women over 40 years of age: how old is too old? Reprod Biomed Online 19:599–603 PubMedCrossRef Hourvitz A, Machtinger R, Maman E et al (2009) Assisted reproduction in women over 40 years of age: how old is too old? Reprod Biomed Online 19:599–603 PubMedCrossRef
16.
Zurück zum Zitat Klinkert ER, Broekmans FJ, Looman CW et al (2005) Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 20:611–615 PubMedCrossRef Klinkert ER, Broekmans FJ, Looman CW et al (2005) Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial. Hum Reprod 20:611–615 PubMedCrossRef
17.
Zurück zum Zitat Kucuk T, Kozinoglu H, Kaba A (2008) Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet 25:123–127 PubMedCentralPubMedCrossRef Kucuk T, Kozinoglu H, Kaba A (2008) Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet 25:123–127 PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat La Marca A, Sighinolfi G, Radi D et al (2010) Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16:113–130 CrossRef La Marca A, Sighinolfi G, Radi D et al (2010) Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16:113–130 CrossRef
19.
Zurück zum Zitat La Marca A, Spada E, Sighinolfi G et al (2011) Age-specific nomogram for the decline in antral follicle count throughout the reproductive period. Fertil Steril 95:684–688 CrossRef La Marca A, Spada E, Sighinolfi G et al (2011) Age-specific nomogram for the decline in antral follicle count throughout the reproductive period. Fertil Steril 95:684–688 CrossRef
20.
Zurück zum Zitat Leridon H (2004) Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod 19:1548–1553 PubMedCrossRef Leridon H (2004) Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment. Hum Reprod 19:1548–1553 PubMedCrossRef
21.
Zurück zum Zitat Lossl K, Andersen CY, Loft A et al (2008) Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod 23:1820–1829 PubMedCrossRef Lossl K, Andersen CY, Loft A et al (2008) Short-term androgen priming by use of aromatase inhibitor and hCG before controlled ovarian stimulation for IVF. A randomized controlled trial. Hum Reprod 23:1820–1829 PubMedCrossRef
22.
Zurück zum Zitat Nardo LG, Bosch E, Lambalk CB, Gelbaya TA (2013) Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb) 16:144–150 Nardo LG, Bosch E, Lambalk CB, Gelbaya TA (2013) Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb) 16:144–150
23.
Zurück zum Zitat Pandian Z, McTavish AR, Aucott L et al (2010) Interventions for „poor responders“ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev:CD004379. DOI 10.1002/14651858.CD004379.pub3 Pandian Z, McTavish AR, Aucott L et al (2010) Interventions for „poor responders“ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF). Cochrane Database Syst Rev:CD004379. DOI 10.1002/14651858.CD004379.pub3
24.
Zurück zum Zitat Pu D, Wu J, Liu J (2011) Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod 26:2742–2749 PubMedCrossRef Pu D, Wu J, Liu J (2011) Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod 26:2742–2749 PubMedCrossRef
25.
Zurück zum Zitat Spandorfer SD, Bendikson K, Dragisic K et al (2007) Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes. Fertil Steril 87:74–76 PubMedCrossRef Spandorfer SD, Bendikson K, Dragisic K et al (2007) Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes. Fertil Steril 87:74–76 PubMedCrossRef
26.
Zurück zum Zitat Tokura Y, Yoshino O, Ogura-Nose S et al (2013) The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment. J Assist Reprod Genet 30:821–825 PubMedCrossRef Tokura Y, Yoshino O, Ogura-Nose S et al (2013) The significance of serum anti-Müllerian hormone (AMH) levels in patients over age 40 in first IVF treatment. J Assist Reprod Genet 30:821–825 PubMedCrossRef
27.
Zurück zum Zitat Disseldorp J van, Faddy MJ, Themmen AP et al (2008) Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93:2129–2134 PubMedCrossRef Disseldorp J van, Faddy MJ, Themmen AP et al (2008) Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 93:2129–2134 PubMedCrossRef
28.
Zurück zum Zitat Rooij IA van, Bancsi LF, Broekmans FJ et al (2003) Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 79:482–488 PubMedCrossRef Rooij IA van, Bancsi LF, Broekmans FJ et al (2003) Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 79:482–488 PubMedCrossRef
29.
Zurück zum Zitat Wiser A, Gonen O, Ghetler Y et al (2010) Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 25:2496–2500 PubMedCrossRef Wiser A, Gonen O, Ghetler Y et al (2010) Addition of dehydroepiandrosterone (DHEA) for poor-responder patients before and during IVF treatment improves the pregnancy rate: a randomized prospective study. Hum Reprod 25:2496–2500 PubMedCrossRef
Metadaten
Titel
Ovarielle Stimulation bei der prä- und perimenopausalen Patientin
verfasst von
Prof. Dr. T. Strowitzki
M. von Wolff
Publikationsdatum
01.04.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Die Gynäkologie / Ausgabe 4/2014
Print ISSN: 2731-7102
Elektronische ISSN: 2731-7110
DOI
https://doi.org/10.1007/s00129-013-3269-9

Weitere Artikel der Ausgabe 4/2014

Der Gynäkologe 4/2014 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.